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A B S T R A C T
Metabolic syndrome is a cluster of obesity-related metabolic abnormalities that lead to metabolic heart disease
(MHD) with left ventricular pump dysfunction. Although MHD is thought to be associated with myocardial
energetic deficiency, two key questions have not been answered. First, it is not known whether there is a suf-
ficient energy deficit to contribute to pump dysfunction. Second, the basis for the energy deficit is not clear. To
address these questions, mice were fed a high fat, high sucrose (HFHS) ‘Western’ diet to recapitulate the MHD
phenotype. In isolated beating hearts, we used 31P NMR spectroscopy with magnetization transfer to determine
a) the concentrations of high energy phosphates ([ATP], [ADP], [PCr]), b) the free energy of ATP hydrolysis
(ΔG~ATP), c) the rate of ATP production and d) flux through the creatine kinase (CK) reaction. At the lowest
workload, the diastolic pressure-volume relationship was shifted upward in HFHS hearts, indicative of diastolic
dysfunction, whereas systolic function was preserved. At this workload, the rate of ATP synthesis was decreased
in HFHS hearts, and was associated with decreases in both [PCr] and ΔG~ATP. Higher work demands unmasked
the inability of HFHS hearts to increase systolic function and led to a further decrease in ΔG~ATP to a level that is
not sufficient to maintain normal function of sarcoplasmic Ca2+-ATPase (SERCA). While [ATP] was preserved at
all work demands in HFHS hearts, the progressive increase in [ADP] led to a decrease in ΔG~ATP with increased
work demands. Surprisingly, CK flux, CK activity and total creatine were normal in HFHS hearts. These findings
differ from dilated cardiomyopathy, in which the energetic deficiency is associated with decreases in CK flux, CK
activity and total creatine. Thus, in HFHS-fed mice with MHD there is a distinct metabolic phenotype of the heart
characterized by a decrease in ATP production that leads to a functionally-important energetic deficiency and an
elevation of [ADP], with preservation of CK flux.
1. Introduction
The United States is in the midst of an obesity epidemic [1]. More
than one third of Americans have metabolic syndrome, a cluster of
obesity-related metabolic abnormalities including type 2 diabetes, hy-
pertension, elevated triglycerides and/or decreased HDL cholesterol
[2]. Patients with metabolic syndrome have an increased risk of sub-
clinical cardiac dysfunction, referred to here as metabolic heart disease
(MHD), that is characterized by left ventricular (LV) hypertrophy and
diastolic dysfunction [3–5]. These patients typically have normal
resting systolic function as reflected by a normal LV ejection fraction,
and may be asymptomatic or progress to clinical heart failure, typically
with a preserved ejection fraction (i.e., HFpEF) [6,7].
Studies in humans with obesity-related MHD have shown a decrease
in the concentration of myocardial phosphocreatine ([PCr]), thereby
supporting the suggestion that there is an imbalance in energy supply
and demand [8]. This thesis is further supported by observations in
genetic or diet-induced models of MHD showing an impaired metabolic
efficiency in working hearts [9]. Likewise, we [10,11] and others
[12,13] have shown that maximal ATP production is decreased in iso-
lated cardiac mitochondria from mice or rats with diet-induced MHD.
However, there are at least two important limitations to our current
understanding of energetics in MHD. First, the basis for the energy
deficit in terms of high energy phosphate fluxes is not clear. Second, it
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is not clear whether the proposed energy deficit is sufficient to result in
a decrease in cardiac pump function. In this study we tested the hy-
potheses that MHD a) causes a decrease in myocardial ATP synthesis in
the intact beating heart, and b) that the resulting decrease in myo-
cardial energy supply is sufficient to depress cardiac function, parti-
cularly, in the face of increased work demand.
MHD was caused by feeding mice a high fat, high sucrose, (HFHS)
“Western” diet for 4months [10,14]. Myocardial function was mea-
sured in the isolated perfused beating heart, and myocardial energetics
were assessed using 31P NMR spectroscopy [15–17]. To determine the
relationship between myocardial energetics and function, we measured
contractile function and high energy phosphates simultaneously over a
range of workloads. Myocardial [ATP], [ADP] and [PCr] were de-
termined. The severity of the energetic deficit was quantitated by de-
termining the free energy of ATP hydrolysis (ΔG~ATP), thus allowing an
assessment of the energetic deficit relative to the known values of
ΔG~ATP required for key cellular processes involved in excitation-con-
traction. The rate constants for ATP synthesis and the creatine kinase
reaction were determined using magnetization transfer, allowing cal-
culation of ATP and PCr fluxes. These observations, which include
novel measurements of ATP synthesis, ΔG~ATP and [ADP] in MHD,
provide the first direct evidence that a deficit in ATP production causes
a decrease in ΔG~ATP sufficient to impair the function of sarcoplasmic




Male C57BL/6J mice 9 weeks of age were fed ad libitum either a
control chow diet (Research Diets, product No. D09071703, 10% kcal
lard, 0% sucrose) or a HFHS diet (Research Diets, product No.
D09071702; 58% kcal lard, 13% kcal sucrose) for 4months. The control
diet (CD) was custom-formulated to match the micronutrients con-
tained in the HFHS diet except for fat and sucrose. (Online
Supplemental Table 1). We have previously reported increased body
weight, increased fat mass, impaired glucose tolerance, fasting hy-
perglycemia and hyperinsulinemia as early as 8 weeks on the HFHS vs.
CD diet [18]. The protocol was approved by the Institutional Animal
Care and Use Committee of the Boston University School of Medicine.
2.2. Basal LV hemodynamic function in isolated perfused beating hearts
Left ventricular (LV) contractile function was assessed in an isolated
retrograde-perfused Langendorff heart preparation in which the LV
pressure/volume (PV) relationship was determined using the iso-
volumic, balloon-in-LV technique that allows assessment of LV function
over a range of volumes that are normalized to heart weight [15]. Mice
were heparinized (100 U IP) and anesthetized with sodium pento-
barbital (150mg/kg IP). The heart was excised, paced at a rate of 450
beats per minute (bpm) and perfused at a constant pressure of
80mmHg. The perfusate consisted of the following (in mmol/L): NaCl
118, NaHCO3 25, KCl 5.3, CaCl2 2, MgSO4 1.2, EDTA 0.5, glucose 10,
pyruvate 0.5 equilibrated with 95% O2 and 5% CO2 (pH 7.4). A water-
filled balloon was inserted into the LV for measurement of LV pressure
and adjustment of LV volume. LV developed pressure (DevP) was de-
termined (DevP= systolic pressure− end diastolic pressure). After
stabilization for 20min, the LV pressure/volume (PV) relationship was
obtained by increasing the balloon volume in 5 μL increments until the
maximum DevP was achieved for each heart [15]. PV curves were de-
termined under basal conditions (450 bpm, 2mM Ca2+). These ex-
periments were performed outside the NMR spectrometer using higher
fidelity hemodynamic measurements in order to optimize the assess-
ment of end-diastolic pressures.
2.3. Simultaneous measurement of LV contractile function and high energy
phosphates by 31P nuclear magnetic resonance (NMR) spectroscopy
In all subsequent studies, contractile function and high energy
phosphates were measured simultaneously. Hearts were isolated as
above and the perfusate was supplemented with glucose (10mM) and
pyruvate (0.5 mM) as energy substrates. In a separate subgroup of ex-
periments, the perfusion buffer was supplemented with mixed long-
chain fatty acids bound to 1% albumin resulting in the following con-
centrations (in mmol/L): palmitic acid (0.21), palmitoleic acid (0.04),
linoleic acid (0.04), oleic acid (0.12), glucose (10) and insulin (50 μU/
mL) [16]. Perfused hearts were placed in a 9.4-Tesla superconducting
magnet and maintained at 37 °C throughout the protocol. After stabi-
lization, balloon volume was adjusted to achieve an end-diastolic
pressure of 8 to 9mmHg, and was held constant for the rest of the
protocol. LV workload was changed by increasing the concentration of
CaCl2 in the perfusate from 2 to 4mM [16], increasing the pacing rate
from 450 bpm to 600 bpm, or both. Heart rates (HR) of 450 and
600 bpm represent resting and high level of exercise (running at 21m/
s) of a C57BL/6 mouse, respectively [19]. Workload was estimated as
the rate× pressure product (RPP=DevP×HR) [16].
High energy phosphates were measured by 31P NMR spectroscopy
(161.4 MHz, 9.4 T) using a Varian VNMRS spectrometer, as we have
described [16,17,20]. NMR spectra were collected for 16min at each
level of work. Each 31P NMR spectrum resulted from the average of 208
free induction decay signals over 8min. A reference capillary with an
external standard (phenylphosphonic acid) was placed in the NMR tube
next to the isolated heart to allow calculation of absolute concentra-
tions of phosphocreatine (PCr), inorganic phosphate (Pi) and ATP
[17,20]. Saturation factors for all resonances were determined from
fully relaxed spectra acquired with a recycle time of 20 s. Intracellular
pH was calculated from the chemical shift of intracellular Pi relative to
PCr [17,20]. At the end of each experiment, hearts were freeze clamped
using Wollenberger tongs pre-cooled in liquid nitrogen and stored at
−80 °C for subsequent analyses.
2.4. Magnetization transfer experiments
In separate hearts, ATP synthesis and the forward CK reaction rates
were measured with the 2-site saturation transfer technique by applying
a low-power narrow-band radiofrequency pulse to saturate γ-ATP re-
sonance and measure changes in the PCr and Pi resonance areas
[16,21]. These measurements were performed at baseline workload
(hearts paced at 450 bpm, 2mM [Ca2+] in the perfusate). Spectra were
acquired without (M0) and with 4.8 s (M∞) application of the selective
saturating pulse. Each spectrum resulted from averaging a total of 256
scans, interleaved between sets of 8M0 and M∞ scans. The M0 and M∞
measurements were acquired in 44min. The unidirectional pseudo–-
first-order rate constant of ATP synthesis was calculated as kf= (M0/
M∞)/T1 M∞ and flux= kf [Pi], where T1 is the intrinsic longitudinal
relaxation time for Pi, [Pi] and M0 and M∞ are magnetizations of Pi at 0
and 4.8 s, respectively. Similarly, for CK forward reaction, the uni-
directional pseudo-first order rate constant kf= (M0/M∞)/T1 M∞ and
flux= kf [PCr], where T1 is the intrinsic longitudinal relaxation time
for PCr and M0 and M∞ are magnetizations of PCr at 0 and 4.8 s, re-
spectively.
2.5. Calculation of the free energy of ATP hydrolysis (ΔG~ATP)
Total creatine concentration [Crtotal] was determined in heart
samples by thin layer chromatography [22].Tissue water content was
assayed by drying a tissue powder aliquot 24 h at 100 °C. The cytosolic
creatine concentration ([Cr]) was calculated as the difference between
[Crtotal] and [PCr] measured by 31P NMR. Despite performing the 31P
NMR spectroscopy ex vivo, free [ADP] could not be measured by 31P
NMR directly [23]. Thus, free [ADP] was calculated using the creatine
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kinase reaction (Eq. (1)), which was assumed to be at equilibrium and
where Keq= 1.66×109M−1 [24]:
=
+[ADP] ([ATP][Cr])/([PCr][H ])Keq (1)
The energy available in [ATP] for chemical work is expressed by the
free energy of ATP hydrolysis (ΔG~ATP), which is calculated by Eq. (2),
where ΔG0 (−30.5 kJ/mol) is the value of ΔG~ATP under standard
conditions of molarity, temperature, pH and [Mg2+], R=8.314 J/
mol·K, and T=310 K [24].
= +|ΔG~ |(kJ/mol) |ΔG RT ln [ADP][P]/[ATP]|ATP
0
i (2)
The value of ΔG~ATP is negative, which denotes that the reaction is
exergonic or energy-releasing. For the sake of clarity, we use the ab-
solute value of ΔG~ATP, |ΔG~ATP|.
2.6. Creatine kinase (CK) activity and protein expression
Total maximal CK activity was measured using a colorimetric
Creatine Kinase Assay Kit according to the manufacturer's protocol
(Abcam, Cambridge, MA) [25]. Briefly, freshly isolated tissue was
homogenized in assay buffer, centrifuged to remove insoluble material,
and supernatant was used for activity and immunoblotting. Protein
concentration in the supernatant was determined by bicinchoninic acid
assay (Pierce). Diluted supernatant (70–140 ng) was combined with
ATP, CK Substrate, CK Enzyme Mix and CK Developer in a 96 well plate
in duplicate, and color development was read at OD 450 nm for 30min.
Standards of NADH dilutions had the same mix without sample. Data is
reported as the U/mg/min, where 1 U is the amount of CK that gen-
erates 1 μmol NADH per minute.
CK immunoblots were performed using the identical supernatants.
Protein (20 μg) was separated by SDS-PAGE, transferred to a PVDF
membrane, and probed with rabbit anti-CK (Abcam) and mouse anti-
GAPDH (Abcam) antibodies. Bands were visualized with IRDye®
800CW Donkey anti-Rabbit IgG and IRDye® 680LT Donkey anti-Mouse
IgG (Licor), and fluorescent intensity was analyzed using a Licor
Odyssey system. Data is reported as CK/GAPDH.
2.7. Statistical analysis
Results are presented as mean ± SEM. Comparisons between
groups were performed using unpaired t-tests, Mann-Whitney non-
parametric tests or 2-way or repeated measures ANOVA, as appropriate.
All statistical analyses were performed using GraphPad Prism software.
P-value < 0.05 was considered significant.
3. Results
3.1. Body and heart weight
All studies were performed after 4months on either the HFHS or
control (CD) diet, at which time the average age was 27 ± 1weeks.
Body weight, heart weight and heart weight normalized to tibia length
were increased in HFHS group. The daily caloric intake was approxi-
mately 11% higher in HFHS group (Table 1). We previously showed
that 4months of HFHS diet leads to LV hypertrophy and diastolic
dysfunction as assessed by trans-mitral and tissue Doppler echo-
cardiography [10,11]. HFHS-fed mice recapitulate many aspects of the
metabolic syndrome, including insulin resistance, increased plasma
triglycerides and hypertension, making them an excellent model to
study obesity-linked cardiovascular complications [18].
3.2. Basal contractile function
Basal function was determined with pacing at 450 bpm and a per-
fusate [Ca2+] of 2mM. In hearts from HFHS-fed (vs. CD-fed) mice the
end-diastolic pressure was elevated over the entire range of LV volumes
tested (Fig. 1A), indicative of impaired LV filling. In hearts from HFHS-
fed (vs. CD-fed) mice LV systolic pressure was higher at low volumes,
but was similar at the highest LV volumes tested (Fig. 1B). The maximal
developed pressure (DevP) achieved was similar in HFHS and CD hearts
(Fig. 1C), and likewise, LV DevP vs. EDP was identical for HFHS vs. CD
hearts over the entire range of LV volumes tested (Fig. 1D). Thus, under
basal conditions HFHS feeding led to diastolic dysfunction with pre-
servation of systolic function confirming our prior echocardiographic
findings [10,11] and showing that this isolated heart preparation ex-
hibits hemodynamic features consistent with MHD.
3.3. Impaired contractile response to increased work
In a separate set of hearts, we next evaluated LV function and en-
ergetics simultaneously over a range of workloads. For these experi-
ments, the LV balloon volume was set to achieve an LV end-diastolic
pressure (LVEDP) of 8–9mmHg under basal conditions (pa-
cing=450 bpm, perfusate [Ca2+]=2mM). Work demand was raised
incrementally by increasing the pacing rate from 450 to 600 bpm and
increasing perfusate calcium from 2 to 4mM, separately and in com-
bination.
By design, LVEDP was identical in the HFHS and CD hearts under
baseline conditions, but increased more in HFHS hearts at each higher
level of work demand (Fig. 2A). At the highest work demand, LVEDP
was 25 ± 2.3mmHg in HFHS hearts vs. 13.9 ± 2.1mmHg in CD
hearts (p < 0.01). In hearts from CD-fed mice, end-systolic pressure
(Fig. 2B), developed pressure (Fig. 2C), and the RPP (Fig. 2D) increased
progressively with higher work levels, whereas in HFHS hearts these
increases where markedly blunted, indicative of a decrease in cardiac
contractile reserve.
To ensure that substrate availability is not responsible for the ob-
served differences in contractile function we perfused hearts with
mixed long-chain fatty acids and insulin in addition to the regular
Krebs-Henseleit (KH) buffer. Supplementation of the perfusate with
mixed long-chain fatty acids and insulin had no effect on the observed
differences in contractile response to high work demand (Supplemental
Fig. 1).
3.4. Decreased high energy phosphate concentrations at baseline and with
increasing workload
Concurrent with hemodynamic measurements, the concentrations
of high-energy phosphates [PCr] and [ATP] were measured using 31P
NMR spectroscopy. The ATP concentration was similar in hearts from
HFHS- and CD-fed mice at baseline and all levels of work demand
(Fig. 3A). As expected [16,17], in hearts from CD-fed mice [PCr] and
PCr/ATP decreased progressively with increasing work demand
(Fig. 3B-C). In hearts from HFHS-fed mice, both [PCr] and the PCr/ATP
ratio were lower at baseline and across all levels of work demand
(Fig. 3B-C). Total [Cr] measured at the end of the study was the same
for CD and HFHS hearts (Supplemental Fig. 2A). Intracellular pH
(Supplemental Fig. 2B) and inorganic phosphate (Supplemental Fig. 2C)
were also the same for both groups at all work levels. In contrast,
Table 1
Body and organ weights.
CD HFHS
Age, weeks 27.1 ± 1.2 26.8 ± 1.1
Body weight, g 28.4 ± 4.0 49.1 ± 5.3⁎
Heart weight, mg 112.2 ± 3.7 148.3 ± 6.5⁎
Tibia length, mm 17.5 ± 0.3 18.1 ± 0.3
Heart weight/tibia length, mg/mm 6.4 ± 0.5 8.2 ± 0.4⁎
Caloric intake, kcal/mouse/day 14.5 ± 0.3 16.2 ± 0.6⁎
Values are mean ± SEM; n=10 in each group.
⁎ P < 0.01.
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cytosolic free [ADP], calculated as per Eq. (1), was higher in HFHS
hearts at baseline and at all levels of work demand (Fig. 3D).
Supplementation of the perfusate with mixed long-chain fatty acids
(LCFA) and insulin had no effect on [ATP], [PCr], the PCr/ATP ratio or
cytosolic free [ADP] measured in CD or HFHS hearts at baseline or with
any workload (Supplemental Fig. 3 A–D).
3.5. Free energy of ATP hydrolysis (ΔG~ATP)
The absolute value of free energy of ATP hydrolysis |ΔGATP| was
lower in HFHS hearts at baseline and at all levels of increased work
demand (Fig. 3E). Of note, at higher levels of work demand |ΔGATP| in
HFHS hearts fell below 52 kJ/mol, the free energy required for normal
function of sarcoplasmic reticulum ATPase (SERCA) [17,26,27].
Supplementation of the perfusate with mixed LCFA and insulin did not
affect |ΔGATP| (Supplemental Fig. 3E).
3.6. High energy phosphate fluxes
To assess ATP synthesis in the intact beating heart, ATP synthesis
and the forward CK reaction rates were measured using the 31P NMR
transfer technique [16,21]. The pseudo-first order rate constant for ATP
synthesis was decreased by 64% in HFHS vs. CD hearts (Fig. 4A), and
flux through the ATP reaction, which reflects the production of ATP,
was decreased by 34% in HFHS hearts (Fig. 4B). In HFHS hearts, the
pseudo-first order rate constant for CKforward was modestly increased
(29%), and flux through CKforward (the product of the rate constant and
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Fig. 1. Diastolic function is impaired while contractile
function is preserved in HFHS- vs. CD-fed hearts under low
workload conditions. LV function was assessed by the iso-
volumic Langendorff method over a range of LV volumes
while hearts were paced at 450 bpm. For any given LV
volume, end-diastolic pressure (EDP) was higher in HFHS-
vs. CD-fed mice, indicating diastolic dysfunction (Panel A).
For HFHS-fed hearts the end-systolic pressure (ESP) - vo-
lume relationship was steeper (Panel B), but the maximal
developed pressures (Panel C) and the relationship be-
tween developed pressure (DevP) and end-diastolic pres-
sure (EDP) (Panel D) were similar to those in CD-fed
hearts. For all panels data are shown as mean ± SEM;
open circles= CD-fed mice and filled circles=HFHS-fed
mice; n=8 in each group; *=p < 0.05.
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Fig. 2. Contractile reserve is decreased in isolated perfused
hearts from HFHS-fed mice. LV contractile function was
assessed at 4 levels of progressively increasing myocardial
work demand. Hearts were paced at heart rate (HR)
450 bpm at baseline, and paced at 600 bpm and/or Ca2+
was raised (4mM) to increase work demand and in com-
petent hearts, contractile performance. With increased
work demand, the LV end-diastolic pressure (EDP) in-
creased more in hearts from HFHS-fed (vs. CD-fed) mice
(Panel A). At baseline demand (2mM Ca2+, 450 bpm),
end-systolic pressure (ESP) (Panel B), developed pressure
(DevP) (Panel C) and the rate x pressure product (RPP)
(Panel D) were all similar in HFHS- and CD-fed hearts.
However, with increased work demand all three measures
failed to increase appropriately. For all panels data are
shown as mean ± SEM; open circles= CD-fed mice and
filled circles=HFHS-fed mice; n= 8 in each group;
*= p < 0.05.
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3.7. CK protein expression and activity
CK protein expression assessed by immunoblotting was unchanged
(vs. CD) in HFHS hearts (Supplemental Fig. 4), as was total CK activity
(Supplemental Fig. 5).
4. Discussion
We used a mouse model of diet-induced MHD characterized by
hemodynamic dysfunction to determine the relationship between en-
ergetics and pump function over a range of work demands in the iso-
lated beating heart. Myocardial energetics were assessed using NMR
spectroscopy to determine the concentrations of high energy phos-
phates, and magnetization transfer was used to determine flux through
the ATP and CK reactions. In addition, for the first time in a beating
heart model of MHD, we determined the free energy of ATP hydrolysis
(ΔG~ATP). There are several new findings. First, ΔG~ATP is decreased in
MHD to an extent sufficient to limit the activity of SERCA. Second, the
rate of ATP synthesis is decreased, while [ATP] is preserved and [ADP]
is increased. Third, although [PCr] is decreased, the CK forward rate
constant is increased, CK activity and total creatine are normal, and the
flux through CK is preserved. It is noteworthy that several of these
findings differ from dilated cardiomyopathy, where the energy defi-
ciency is associated with decreases in CK activity and flux, or have not
been studied (e.g., ATP flux).
4.1. Diastolic dysfunction at low work demand
Under low work conditions (450 bpm, corresponding to resting
mouse heart rate [19], and a normal Ca2+ concentration) there was
clear evidence of diastolic dysfunction in the HFHS hearts as reflected
by higher LV end-diastolic pressures over a range of LV volumes. This
was evident even at low LV volumes well within the physiologic range
of LVEDP of 0–35mmHg. We previously showed that HFHS feeding for
Fig. 3. Energetic function is impaired in isolated perfused hearts from HFHS-fed mice. Concurrent with hemodynamic measurements at progressively increasing levels of work demand
(Fig. 2), myocardial high energy phosphates were measured using 31P NMR spectroscopy. Stack of representative 31P NMR spectra at each stage of the protocol is shown in Panel A (CD)
and Panel D (HFHS). ATP concentrations ([ATP]) were similar in HFHS- and CD-fed hearts at all work demands (Panel B). However, in HFHS hearts the concentration of phosphocreatine
(PCr; Panel C) and the PCr/ATP ratio (Panel E) were lower at baseline and at all workloads, reflecting an impairment in energy reserve. Calculated cytosolic free [ADP] was higher in
HFHS- vs. CD-fed hearts at baseline and all increased workloads (Panel F). The energy available for chemical work in ATP is expressed by the free energy of ATP hydrolysis (ΔG~ATP). As
ΔGATP is a negative number due to the exergonic nature of ATP hydrolysis, the absolute value is depicted for the sake of clarity. |ΔG∼ATP| was lower in HFHS-fed hearts at baseline and all
stages of work demand (Panel G). The lack of energy reserve in HFHS group is even better visualized when |ΔG∼ATP| is plotted against actual work performed, RPP (Panel H). In panels G
and H, the dotted horizontal line at a |ΔG∼ATP| of 52 kJ/mol is the value required for normal function of sarcoplasmic reticulum calcium ATP-ase. For all panels data are shown as
mean ± SEM; open circles= CD-fed mice and filled circles=HFHS-fed mice; n= 8 in each group; *= p < 0.05.
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4months led to diastolic dysfunction in mice in vivo as reflected by
abnormal LV filling and slowed LV relaxation measured by Doppler
echocardiography [10]. The current ex vivo finding of impaired dia-
stolic function in the isolated beating heart is consistent with our prior
in vivo echocardiographic findings, showing that the diastolic dys-
function we observed in the isolated beating heart is of physiologic
relevance.
Under low work conditions systolic function was preserved in HFHS
hearts as evidenced by maximal LV end-systolic and developed pres-
sures that were comparable to CD hearts over a wide range of LV vo-
lumes. Of note, the relationship between DevP and EDP (Fig. 1D) is
nearly identical for HFHS and CD hearts over the entire LV volume
range, further indicating that myocardial systolic function is preserved
when the work demand is low.
4.2. Decreased contractile reserve with increased work demand
In CD hearts, increasing the work demand led to a progressive in-
crease in contractile function. In HFHS hearts the expected increases in
ESP, DevP and RPP were all markedly depressed across the range of
work levels. Thus, an increase in work demand revealed a marked
impairment in the contractile reserve in HFHS hearts as evidenced by
failure to increase systolic function despite an excessive increase in
diastolic filling pressure. These results are similar to the lack of con-
tractile reserve observed in patients with HFpEF [6,28,29], a clinical
syndrome that is frequently caused by MHD.
4.3. [PCr] is decreased in HFHS hearts
We found that myocardial [PCr] was markedly depressed in HFHS
(vs. CD) hearts at all work levels. [PCr] and the [PCr]/[ATP] ratio are
decreased in animal models of systolic heart failure [30–32] and hu-
mans with systolic failure due to dilated cardiomyopathy [32,33]. More
limited data suggest that [PCr] is also decreased in animals [34] and
humans with MHD due to type 2 diabetes [35] or obesity [8]. The
functional importance of a decrease in [PCr] has been linked to a
thermodynamic limitation for Ca2+ handling [24,27]. A decrease in the
PCr/ATP ratio predicts mortality in patients with dilated cardiomyo-
pathy [33], and correlates with diastolic dysfunction in patients with
obesity [8].
4.4. [ATP] is preserved and [ADP] is increased in HFHS hearts
[ATP] was normal in the HFHS hearts. Given the observed decrease
in PCr, this finding was perhaps surprising, and differs from some stu-
dies in dilated CMP in which [ATP] was shown to be decreased [36,37].
However, [ATP] is normal in other studies in dilated CMP [30], the
disparity likely reflecting the severity of myocardial failure [31]. As
predicted by the creatine kinase equilibrium equation (Eq. (1)), the
observed decrease in [PCr]/[ATP] was associated with marked eleva-
tion in free [ADP] (Fig. 3D). In dilated cardiomyopathy there is de-
pletion of total creatine [38,39], which may help to preserve normal
[ADP] and |ΔG∼ATP| [36]. In contrast to dilated cardiomyopathy, [total
creatine] was normal in HFHS hearts (Supplemental Fig. 2A). An in-
crease in [ADP] may contribute to the observed diastolic dysfunction,
as failure to maintain a low [ADP] has been shown to impair diastolic
dysfunction in hypertrophied myocardium [40]. To our knowledge, this
is the first determination of [ADP] in animals or humans with MHD.
4.5. The free energy of ATP hydrolysis (ΔG~ATP) is decreased in HFHS
hearts
It has been assumed that a decrease in [PCr] reflects a state of
“energy starvation” in patients and animal models of dilated cardio-
myopathy/systolic heart failure [31,32]. Likewise, [PCr] is decreased in
MHD, suggesting that an energy deficiency also exists in MHD
[10,12,34,41]. However, it is not known whether the energy deficit in
MHD, as reflected by a decrease in [PCr], is sufficient to contribute to
pump dysfunction. This question is further raised by our finding that
[ATP] is normal in HFHS hearts. To address this important issue, we
Fig. 4. Representative 31P NMR magnetization transfer spectra. Spectra were collected from CD and HFHS hearts at 0 s (M0) and 4.8 s (M∞) after a saturating pulse was applied to γ-P of
the ATP. The peaks are assigned (from left to right) as Pi, PCr, γ-ATP, ⍺-ATP and β-ATP. Note the disappearance of the γ-ATP peak (saturated) at M∞. The exchange of the saturated [γ-P]
between ATP and Pi resulted in reduced Pi peak area (decrease is larger in CD heart than in HFHS heart reflecting higher rate of ATP synthesis). Similarly, the decrease in PCr peak area
reflects the CK forward flux. These measurements were performed at baseline workload with 2mM [Ca2+] in the perfusate and paced at 450 bpm.
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determined the free energy available for ATP hydrolysis (ΔG~ATP),
which is the driving force that powers cellular ATP-requiring processes.
In HFHS hearts |ΔG∼ATP| was lower at baseline (relative to CD
hearts). In addition, |ΔG∼ATP| decreased progressively as work demand
increased (see Fig. 4E) [26,27,39]. In the heart, |ΔG∼ATP| is estimated
to be 54–60 kJ/mol [26], which is adequate to support the |ΔG∼ATP|
requirements for proper function of the major myocyte ATPase reac-
tions including sarcoplasmic reticulum Ca2+-ATPase (SERCA;
52–53 kJ/mol), Na+-K+-ATPase (48 kJ/mol), and actomyosin ATPase
(45–50 kJ/mol) [26]. Of particular note, with increased work demand
|ΔG∼ATP| decreased below the value of 52 kJ/mol that is thought to be
critical for support of the normal function of SERCA, an enzyme that is
particularly susceptible to even modest decreases in ΔG~ATP
[17,26,27]. Myocardial relaxation is highly ATP dependent [40], as the
reuptake of calcium into the sarcoplasmic reticulum by SERCA is ex-
quisitely sensitive to ATP depletion [17,26,27,39]. Adequate SERCA
function is also critical to replenishing SR calcium stores that are re-
quired for normal systolic function. When |ΔG∼ATP| is decreased by
pharmacologic methods the hemodynamic consequences are similar to
those we observed in HFHS-fed hearts, with diastolic dysfunction at
baseline [42] and impaired contractile reserve at higher workloads
[24]. To our knowledge, this is the first measurement of ΔG~ATP in a
model of MHD.
4.6. ATP flux (synthesis) is decreased in HFHS hearts
It is important to note that the concentrations of high energy
phosphates [ATP], [ADP], [PCr] as well as the |ΔG∼ATP| describe the
thermodynamic status of the heart and reflect the relationship between
the ATP synthesis and demand i.e. high energy phosphate kinetics.
Thus, to further elucidate the mechanism responsible for the decrease in
|ΔG∼ATP|, we used magnetization transfer studies to determine the ATP
synthesis rate constant and the flux of ATP. These experiments showed
that, even under low work demand, both the rate constant ATP
synthesis (ADP+Pi→ ATP) and ATP flux were depressed in HFHS
hearts. These results indicate an impairment in ATP synthesis in HFHS-
fed hearts. This finding has been suggested by prior observations based
on indirect methods, e.g. oxygen consumption [9,12] or in isolated
mitochondria [10,11]. The current study provides the first direct de-
monstration that ATP synthesis, per se, is decreased in MHD.
That the concentration of ATP is maintained in HFHS hearts, despite
a decrease in ATP synthesis, indicates that ATP utilization must also be
decreased. A decrease in ATP utilization may reflect ATPase inhibition
by an elevated [ADP] that is known to occur [43]. Alternatively, or in
addition, we cannot exclude the possibility that ATPase's are inhibited
by other factors such as oxidative modifications. In either case, the
observed decrease in ATPase activity may help to preserve [ATP] in the
face of a decrease in synthesis, albeit, at the expense of a decrease in
myocyte work performed [39]. Importantly, our findings are consistent
with previously published in vivo studies from normal [44] and hy-
pertrophied hearts [45,46].
4.7. CK flux is preserved in HFHS hearts
In contrast to the observed decrease in ATP synthesis in HFHS-fed
hearts, we found that the forward rate constant for CK (CKforward), CK
flux, CK protein expression and total CK activity measured biochemi-
cally were all preserved in HFHS hearts. Taken together, these ob-
servations suggest that impaired CK function is not responsible for the
observed decrease in [PCr].
While decreased CK activity has been observed in systolic heart
failure [31,32] and hypertrophic cardiomyopathy [47], relatively little
is known about CK function in MHD. Of note, our findings are con-
sistent with those of Bashir et al. [34], who likewise found that the
forward CK reaction rate constant was higher and CK flux was pre-
served in hearts from diabetic Zucker Diabetic Fatty (ZDF) rats. Taken
together with the findings in the ZDF rat, our data suggest that a de-
crease in CK activity is not a major driver of cardiac energetic defi-
ciency in the cardiomyopathy of MHD, but rather, support the thesis
proposed by Bashir et al. [34] that the increase in the CK rate constant
is a compensatory response that helps to maintain a normal flux
through CK in the face of a decrease in [PCr] [34]. Interestingly, in
other models of HFpEF such as pressure overload [48] and hypertrophic
cardiomyopathy [47] CK flux is decreased, suggesting that the energetic
profile in “HFpEF” may be heterogeneous and related to the underlying
etiology.
4.8. Creatine as “dispensable metabolite”
Important consideration is that creatine was somewhat con-
troversially [49] shown to be a ‘dispensable metabolite’ in the heart
[50]. In our study, we use the PCr/ATP ratio and creatine content to
calculate ADP concentration and ΔG~ATP. If there were no creatine in
the heart this approach would not be possible. A similar situation is
present in the liver where there is no CK expression and thus no PCr.
However, when CK was genetically introduced in the liver, ADP con-
centration measured by 31P NMR (PCr/ATP) was in agreement with
biochemical measurements [51]. Thus, in the presence of a CK system,
[PCr] is useful in assessing ΔG~ATP, the ultimate driving force for en-
ergy requiring processes in the cell [39].
4.9. Potential limitations
Since our standard perfusion buffer is devoid of fatty acids, it was
possible that the energetic deficit in HFHS hearts was a consequence of
insufficient fatty acids in the buffer. Circulating fatty acids are an im-
portant source of energy for the healthy heart [52] and likely may take
on increased importance in HFHS-fed hearts that have been exposed to
increased fatty acids chronically [13,53]. However, supplementation of
the perfusion buffer with mixed long chain fatty acids (LCFA) did not
improve energetic or pump function in HFHS hearts, suggesting that
under the conditions of these experiments the availability of exogenous
LCFA is not limiting. We cannot exclude the possibility that the meta-
bolic state caused by the HFHS diet leads to abnormalities in myo-
cardial substrate utilization. Likewise, it is possible that the defects in
mitochondrial function are independent of the metabolic substrate
supplied [10,11]. In this study |ΔG∼ATP| represents the average value
across the heart and thus would not reflect potential local variations in
the concentrations of high energy phosphates with regard to sarco-
plasmic reticulum and other cellular micro-compartments.
4.10. Clinical relevance
Obesity, type 2 diabetes and metabolic syndrome are strongly as-
sociated with the development of heart failure with preserved ejection
fraction (HFpEF) [3–6]. While the integrated pathophysiology of HFpEF
is complex and incompletely understood, it is clear that LV diastolic
dysfunction is a major contributor [6,7,54]. Our observations indicate
that impaired energy production may contribute to diastolic dysfunc-
tion in MHD. It is noteworthy that a decrease in the myocardial [PCr]/
[ATP] ratio has been shown to correlate with the severity of impaired
LV relaxation in patients with obesity-related heart disease [8,29].
These findings also suggest that impaired systolic function in this set-
ting may only become evident when cardiac work is increased, thus
emphasizing the importance of studying this pathophysiology under
conditions of varying cardiac work. Clinically, in patients with HFpEF,
exercise is an important precipitant of symptoms and elevated pul-
monary artery pressures [6,28,55]. Likewise, symptoms and exercise
intolerance correlate poorly with the degree of diastolic dysfunction
assessed at rest [6]. Our findings suggest that the inability to increase
cardiac work due to energetic limitations may be an important cause of
exercise intolerance and symptoms in patients with HFpEF. Peripheral
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factors, some energetic, may contribute to exercise intolerance in
HFpEF as well [56]. Thus, while we cannot exclude a role for other
factors (e.g., increased myocardial stiffness due to fibrosis or altered
properties/function of titin), therapeutic strategies to improve myo-
cardial energetics may be of value in the treatment of HFpEF in the
setting of MHD due to obesity, type 2 diabetes and/or metabolic syn-
drome (Table 2).
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